109 related articles for article (PubMed ID: 3621937)
1. Termination of early gestation with the anti-progestin steroid RU 486: medium versus low dose.
Mishell DR; Shoupe D; Brenner PF; Lacarra M; Horenstein J; Lahteenmaki P; Spitz IM
Contraception; 1987 Apr; 35(4):307-21. PubMed ID: 3621937
[TBL] [Abstract][Full Text] [Related]
2. Early pregnancy termination with antiprogestins: a comparative clinical study of RU 486 given in two dose regimens and Epostane.
Birgerson L; Odlind V
Fertil Steril; 1987 Oct; 48(4):565-70. PubMed ID: 3653415
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy termination with a high and medium dosage regimen of RU 486.
Shoupe D; Mishell DR; Brenner PF; Spitz IM
Contraception; 1986 May; 33(5):455-61. PubMed ID: 3757511
[TBL] [Abstract][Full Text] [Related]
4. Termination of very early pregnancy by RU 486--an antiprogestational compound.
Kovacs L; Sas M; Resch BA; Ugocsai G; Swahn ML; Bygdeman M; Rowe PJ
Contraception; 1984 May; 29(5):399-410. PubMed ID: 6744860
[TBL] [Abstract][Full Text] [Related]
5. Termination of early pregnancy by a single dose of mifepristone (RU 486), a progesterone antagonist.
Maria B; Stampf F; Goepp A; Ulmann A
Eur J Obstet Gynecol Reprod Biol; 1988 Jul; 28(3):249-55. PubMed ID: 3208966
[TBL] [Abstract][Full Text] [Related]
6. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.
Rodger MW; Baird DT
Lancet; 1987 Dec; 2(8573):1415-8. PubMed ID: 2891991
[TBL] [Abstract][Full Text] [Related]
7. Induction of abortion in early first trimester human pregnancy using epostane.
Webster MA; Gillmer MD
Br J Obstet Gynaecol; 1989 Mar; 96(3):340-5. PubMed ID: 2713292
[TBL] [Abstract][Full Text] [Related]
8. The use of the antiprogestin RU486 (mifepristone) as an abortifacient in early pregnancy--clinical and pathological findings; predictive factors for efficacy.
Sitruk-Ware R; Thalabard JC; De Plunkett TL; Lewin F; Epelboin S; Mowszowicz I; Yaneva H; Tournaire M; Chavinie J; Mauvais-Jarvis P
Contraception; 1990 Mar; 41(3):221-43. PubMed ID: 2323217
[TBL] [Abstract][Full Text] [Related]
9. Interruption of early pregnancy by an anti-progestational compound, RU 486.
Haspels AA
Eur J Obstet Gynecol Reprod Biol; 1985 Sep; 20(3):169-75. PubMed ID: 4054413
[TBL] [Abstract][Full Text] [Related]
10. Medical abortion in women of less than or equal to 56 days amenorrhoea: a comparison between gemeprost (a PGE1 analogue) alone and mifepristone and gemeprost.
Norman JE; Thong KJ; Rodger MW; Baird DT
Br J Obstet Gynaecol; 1992 Jul; 99(7):601-6. PubMed ID: 1525104
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P
Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
[TBL] [Abstract][Full Text] [Related]
12. Early abortion induction by a combination of mifepristone and oral misoprostol: a comparison between two dose regimens of misoprostol and their effect on blood pressure.
el-Refaey H; Templeton A
Br J Obstet Gynaecol; 1994 Sep; 101(9):792-6. PubMed ID: 7947529
[TBL] [Abstract][Full Text] [Related]
13. Changes in the concentration of alpha-fetoprotein and placental hormones following two methods of medical abortion in early pregnancy.
Thong KJ; Norman JE; Baird DT
Br J Obstet Gynaecol; 1993 Dec; 100(12):1111-4. PubMed ID: 7507707
[TBL] [Abstract][Full Text] [Related]
14. The antiprogestational agent RU 486 as an abortifacient in early human pregnancy: a comparison of three dose regimens.
Birgerson L; Odlind V
Contraception; 1988 Oct; 38(4):391-400. PubMed ID: 3208513
[TBL] [Abstract][Full Text] [Related]
15. Clinical, hormonal and sonographic predictors of successful RU-486-induced abortions.
Menashe Y; Bider D; Shalev J; Pariente C; Serr DM
Gynecol Obstet Invest; 1995; 40(2):108-12. PubMed ID: 8575686
[TBL] [Abstract][Full Text] [Related]
16. Termination of early human pregnancy with epostane.
Birgerson L; Olund A; Odlind V; Somell C
Contraception; 1987 Feb; 35(2):111-20. PubMed ID: 3595138
[TBL] [Abstract][Full Text] [Related]
17. Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG.
Croxatto HB; Salvatierra AM; Croxatto HD; Spitz IM
Clin Endocrinol (Oxf); 1989 Jul; 31(1):15-23. PubMed ID: 2598478
[TBL] [Abstract][Full Text] [Related]
18. Emergency contragestion.
Schaison G
Contraception; 1987; 36 Suppl():7-11. PubMed ID: 2445524
[TBL] [Abstract][Full Text] [Related]
19. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE
J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
[TBL] [Abstract][Full Text] [Related]
20. Effects of the antiprogesterone RU 486 in normal women. I. Single-dose administration in the midluteal phase.
Shoupe D; Mishell DR; Lahteenmaki P; Heikinheimo O; Birgerson L; Madkour H; Spitz IM
Am J Obstet Gynecol; 1987 Dec; 157(6):1415-20. PubMed ID: 2827481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
